← All Sponsors
SPONSOR

Grey Wolf Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Axial Spondyloarthritis (AxSpA)
NCT07047703 Phase 1, Phase 2
Recruiting

EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)

Axial Spondyloarthritis (AxSpA)
Australia, Belgium, Germany View Trial →